Posted in | News | Solar Energy

Beneq-Glaston Secure Order for First TCO Coating Line for Photovoltaics

The first Beneq-Glaston TFC2000™ line for manufacturing TCO coatings on glass for photovoltaics (PV) has been sold to Asia. The total order is approximately EUR 14 million, of which Glaston’s share is over EUR 4 million. The line delivery is scheduled for Q1 of 2012.

Beneq CEO, Mr Sampo Ahonen, comments: “This is a definitive demonstration of the growing need for high-quality TCO-glass and coating equipment to manufacture it. It is also good proof of the seamless cooperation between Beneq and Glaston, which with this transaction has taken a giant leap forward.”

In September 2010, Beneq and Glaston announced their strategic cooperation for solar glass coating equipment. Results of the collaboration between the companies brought about the new TFC2000™ continuous offline production concept, which enables a commercially affordable way to manufacture high-quality TCO coated glass for the solar industry. The Beneq coating system, featuring unique and proprietary nAERO® technology, is fully integrated into Glaston’s CHF Pro™ heat treatment line. The TFC2000™ combines world-leading glass and annealing technology with advanced thin film coating for rapidly growing solar applications.”

“The sale of the first TFC2000™ line in such a relatively short period of time is very encouraging and confirms that the joint Beneq-Glaston offering has been well positioned to serve the needs of the growing thin film PV industry with a solution that is unique and competitive”, Glaston CEO Mr Arto Metsänen comments.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.